ALLIANCE PHARMA PLC

("Alliance" or the "Group")

Annual Report and Accounts and Notice of AGM

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that the Annual Report & Accounts for the year ended 31 December 2023 (the "2023 Annual Report") was published and made available on 19 June 2024 on the Group's website, www.alliancepharmaceuticals.com.

Printed copies of the 2023 Annual Report were mailed to those shareholders who have opted out of receiving electronic communications from the Group.

Alliance also announces that the Notice of the 2024 Annual General Meeting, which will be held at 10.00 am on 29 July 2024, has been made available on the Group's website, www.alliancepharmaceuticals.com; and printed copies were mailed to those shareholders who have opted out of receiving electronic communications from the Group.

Printed copies of both documents are also available by contacting Burson Buchanan by email at alliancepharma@buchanan.uk.com or by telephoning 020 7466 5000.

For further information:

About Alliance

Alliance Pharma plc (AIM: APH) is a growing consumer healthcare company. Our purpose is to empower people to make a positive difference to their health and wellbeing by making our trusted and proven brands available around the world.

We deliver organic growth through investing in our priority brands and channels, in related innovation, and through selective geographic expansion to increase the reach of our brands. Periodically, we may look to enhance our organic growth through selective, complementary acquisitions.

Headquartered in the UK, the Group employs around 285 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics we remain asset-light and focused on maximising the value we can bring, both to our stakeholders and to our brands.

For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com